The 1 analysts offering 12-month price forecasts for Yumanity Therapeutics Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +402.79% increase from the last price of 1.79.
The current consensus among 1 polled investment analysts is to Buy stock in Yumanity Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.15
Reporting Date Mar 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.